Filing metadata

Accession number
0000950170-24-099269
Form type
Form 4
Filer
BridgeBio Pharma, Inc.
CIK
CIK 1743881
Filed
Aug 20, 2024
Reporting period
Aug 16, 2024
Description
Insider transaction

Explore SEC Filings Hub